Damona is focused on discovering and developing precision neuromedicines for patients living with cognitive deficits associated with neurodegenerative and psychiatric disorders such as Alzheimer’s disease, depression, and schizophrenia.
A4i (App4Independence) is a platform for supporting people with complex behavioural and mental health conditions. Currently, A4i is being used to support the recovery processes in psychosis and schizophrenia, and newly in opioid use disorders.
